Back

HAPI Cells are SIM-A9-related Mouse Microglial Cells Useful for In Vitro Modeling of Microglial Immunometabolism

Mayers, R. P.; Jaber, S. M.; Verhoeven, N.; Jaiyesimi, A.; Polster, B. M.

2026-02-14 neuroscience
10.64898/2026.02.11.705385 bioRxiv
Show abstract

Highly aggressively proliferating immortalized (HAPI) cells were initially described as a spontaneously immortalized rat cell line isolated from a mixed neonatal rat glial population. It was demonstrated that HAPI cells are phagocytic, stain for macrophage-/microglia-specific markers like CD11b and GLUT5, and exhibit lipopolysaccharide (LPS)-induced nitric oxide (NO) and tumor necrosis factor-alpha (TNF-) release. These characteristics led to their widespread use as a rat microglial cell line. Here, we report that HAPI cells are mouse cells, not rat cells, but further establish that they have a microglia-like identity and properties useful for in vitro modeling. Cell line authentication by short tandem repeat (STR) profiling, a method that detects identifying DNA signatures, indicates that HAPI cells are a 100% match for SIM-A9 cells, a mouse microglial cell line reported to be spontaneously immortalized from primary cell culture. We find that both HAPI cells and SIM-A9 cells express the microglia-selective gene Tmem119, as well as the microglia-/macrophage-selective marker Cx3cr1, supporting a microglial origin. Like primary rodent microglia or macrophages, HAPI cells respond to combined stimulation with LPS and the Type II interferon, interferon-gamma (IFN-{gamma}), with a pro-inflammatory morphology, NO production, NO-dependent suppression of mitochondrial oxygen consumption, and increased extracellular acidification (an indicator of glycolysis). The Type I interferon, interferon-alpha (IFN-), also reduces mitochondrial oxygen consumption when administered alone or in combination with LPS. Overall, results indicate that HAPI cells are SIM-A9-related mouse cells of microglial origin and support their continued use to study microglial behavior in vitro, including immunometabolism.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Glia
74 papers in training set
Top 0.1%
17.3%
2
Journal of Neuroinflammation
50 papers in training set
Top 0.1%
12.3%
3
eneuro
389 papers in training set
Top 0.3%
12.2%
4
Scientific Reports
3102 papers in training set
Top 28%
4.3%
5
Journal of Neurochemistry
50 papers in training set
Top 0.1%
4.3%
50% of probability mass above
6
PLOS ONE
4510 papers in training set
Top 40%
3.5%
7
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
3.5%
8
Cell Reports
1338 papers in training set
Top 15%
3.5%
9
International Journal of Molecular Sciences
453 papers in training set
Top 5%
2.3%
10
Journal of Neuroscience Research
25 papers in training set
Top 0.1%
1.9%
11
Brain Research
35 papers in training set
Top 0.7%
1.8%
12
Brain, Behavior, and Immunity
105 papers in training set
Top 1%
1.7%
13
Journal of Cell Science
353 papers in training set
Top 1%
1.6%
14
Cells
232 papers in training set
Top 3%
1.3%
15
ASN Neuro
10 papers in training set
Top 0.1%
1.3%
16
Journal of Biological Chemistry
641 papers in training set
Top 3%
1.2%
17
iScience
1063 papers in training set
Top 23%
1.1%
18
Frontiers in Neuroscience
223 papers in training set
Top 6%
0.9%
19
Frontiers in Cellular Neuroscience
79 papers in training set
Top 1%
0.7%
20
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.7%
21
Life Science Alliance
263 papers in training set
Top 2%
0.7%
22
Cell Reports Methods
141 papers in training set
Top 6%
0.7%
23
Nature Communications
4913 papers in training set
Top 64%
0.7%
24
Molecular Neurobiology
50 papers in training set
Top 1%
0.7%
25
eLife
5422 papers in training set
Top 62%
0.6%
26
Stem Cell Reports
118 papers in training set
Top 1%
0.6%
27
Translational Psychiatry
219 papers in training set
Top 5%
0.6%
28
ACS Chemical Neuroscience
60 papers in training set
Top 3%
0.6%